Titre : Génome viral

Génome viral : Questions médicales fréquentes

Termes MeSH sélectionnés :

Hepatitis B virus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Génome viral : Questions médicales les plus fréquentes", "headline": "Génome viral : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Génome viral : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-18", "dateModified": "2025-04-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Génome viral" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Génome microbien", "url": "https://questionsmedicales.fr/mesh/D064349", "about": { "@type": "MedicalCondition", "name": "Génome microbien", "code": { "@type": "MedicalCode", "code": "D064349", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Gènes viraux", "alternateName": "Genes, Viral", "url": "https://questionsmedicales.fr/mesh/D005814", "about": { "@type": "MedicalCondition", "name": "Gènes viraux", "code": { "@type": "MedicalCode", "code": "D005814", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Gènes env", "alternateName": "Genes, env", "url": "https://questionsmedicales.fr/mesh/D015752", "about": { "@type": "MedicalCondition", "name": "Gènes env", "code": { "@type": "MedicalCode", "code": "D015752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.172" } } }, { "@type": "MedicalWebPage", "name": "Gènes gag", "alternateName": "Genes, gag", "url": "https://questionsmedicales.fr/mesh/D015750", "about": { "@type": "MedicalCondition", "name": "Gènes gag", "code": { "@type": "MedicalCode", "code": "D015750", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.258" } } }, { "@type": "MedicalWebPage", "name": "Gènes précoces", "alternateName": "Genes, Immediate-Early", "url": "https://questionsmedicales.fr/mesh/D017781", "about": { "@type": "MedicalCondition", "name": "Gènes précoces", "code": { "@type": "MedicalCode", "code": "D017781", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.345" } } }, { "@type": "MedicalWebPage", "name": "Gènes de particule intracisternale de type A", "alternateName": "Genes, Intracisternal A-Particle", "url": "https://questionsmedicales.fr/mesh/D007426", "about": { "@type": "MedicalCondition", "name": "Gènes de particule intracisternale de type A", "code": { "@type": "MedicalCode", "code": "D007426", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.360" } } }, { "@type": "MedicalWebPage", "name": "Gènes nef", "alternateName": "Genes, nef", "url": "https://questionsmedicales.fr/mesh/D015754", "about": { "@type": "MedicalCondition", "name": "Gènes nef", "code": { "@type": "MedicalCode", "code": "D015754", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.600" } } }, { "@type": "MedicalWebPage", "name": "Gènes pol", "alternateName": "Genes, pol", "url": "https://questionsmedicales.fr/mesh/D015751", "about": { "@type": "MedicalCondition", "name": "Gènes pol", "code": { "@type": "MedicalCode", "code": "D015751", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.667" } } }, { "@type": "MedicalWebPage", "name": "Gènes pX", "alternateName": "Genes, pX", "url": "https://questionsmedicales.fr/mesh/D016355", "about": { "@type": "MedicalCondition", "name": "Gènes pX", "code": { "@type": "MedicalCode", "code": "D016355", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.735" } } }, { "@type": "MedicalWebPage", "name": "Gènes rev", "alternateName": "Genes, rev", "url": "https://questionsmedicales.fr/mesh/D015757", "about": { "@type": "MedicalCondition", "name": "Gènes rev", "code": { "@type": "MedicalCode", "code": "D015757", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.775" } } }, { "@type": "MedicalWebPage", "name": "Gènes tat", "alternateName": "Genes, tat", "url": "https://questionsmedicales.fr/mesh/D015756", "about": { "@type": "MedicalCondition", "name": "Gènes tat", "code": { "@type": "MedicalCode", "code": "D015756", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.850" } } }, { "@type": "MedicalWebPage", "name": "Gènes vif", "alternateName": "Genes, vif", "url": "https://questionsmedicales.fr/mesh/D016341", "about": { "@type": "MedicalCondition", "name": "Gènes vif", "code": { "@type": "MedicalCode", "code": "D016341", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.890" } } }, { "@type": "MedicalWebPage", "name": "Gènes vpr", "alternateName": "Genes, vpr", "url": "https://questionsmedicales.fr/mesh/D016334", "about": { "@type": "MedicalCondition", "name": "Gènes vpr", "code": { "@type": "MedicalCode", "code": "D016334", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.897" } } }, { "@type": "MedicalWebPage", "name": "Gènes vpu", "alternateName": "Genes, vpu", "url": "https://questionsmedicales.fr/mesh/D016338", "about": { "@type": "MedicalCondition", "name": "Gènes vpu", "code": { "@type": "MedicalCode", "code": "D016338", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.340.358.840.500.900" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Génome viral", "alternateName": "Genome, Viral", "code": { "@type": "MedicalCode", "code": "D016679", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Kiramage Chathuranga", "url": "https://questionsmedicales.fr/author/Kiramage%20Chathuranga", "affiliation": { "@type": "Organization", "name": "College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea." } }, { "@type": "Person", "name": "Jong-Soo Lee", "url": "https://questionsmedicales.fr/author/Jong-Soo%20Lee", "affiliation": { "@type": "Organization", "name": "College of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Korea. jongsool@cnu.ac.kr." } }, { "@type": "Person", "name": "Alfred A Antson", "url": "https://questionsmedicales.fr/author/Alfred%20A%20Antson", "affiliation": { "@type": "Organization", "name": "York Structural Biology Laboratory, Department of Chemistry, University of York, York, UK. fred.antson@york.ac.uk." } }, { "@type": "Person", "name": "Stephen S-T Yau", "url": "https://questionsmedicales.fr/author/Stephen%20S-T%20Yau", "affiliation": { "@type": "Organization", "name": "Department of Mathematical Sciences, Tsinghua University, Beijing, 100084, People's Republic of China." } }, { "@type": "Person", "name": "Anouk Willemsen", "url": "https://questionsmedicales.fr/author/Anouk%20Willemsen", "affiliation": { "@type": "Organization", "name": "Laboratory MIVEGEC (UMR CNRS IRD University of Montpellier), Centre National de la Recherche Scientifique (CNRS), 911 Avenue Agropolis, BP 64501, 34394 Montpellier cedex 5, France." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Plerixafor and resatorvid inhibit hepatitis B virus", "datePublished": "2023-02-20", "url": "https://questionsmedicales.fr/article/36891156", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcimb.2023.1118801" } }, { "@type": "ScholarlyArticle", "name": "Hepatitis B Virus Research in South Africa.", "datePublished": "2022-08-31", "url": "https://questionsmedicales.fr/article/36146747", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/v14091939" } }, { "@type": "ScholarlyArticle", "name": "Occult Hepatitis B Virus Infection: An Update.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35891484", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/v14071504" } }, { "@type": "ScholarlyArticle", "name": "Hepatitis B Virus-Associated Hepatocellular Carcinoma.", "datePublished": "2022-05-07", "url": "https://questionsmedicales.fr/article/35632728", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/v14050986" } }, { "@type": "ScholarlyArticle", "name": "Mutations in the S gene of hepatitis B virus in three generations of patients with chronic hepatitis B.", "datePublished": "2023-06-12", "url": "https://questionsmedicales.fr/article/37308753", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11262-023-02012-z" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Génome", "item": "https://questionsmedicales.fr/mesh/D016678" }, { "@type": "ListItem", "position": 5, "name": "Génome microbien", "item": "https://questionsmedicales.fr/mesh/D064349" }, { "@type": "ListItem", "position": 6, "name": "Génome viral", "item": "https://questionsmedicales.fr/mesh/D016679" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Génome viral - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Génome viral", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Génome viral", "description": "Comment détecte-t-on un génome viral ?\nQuels tests sont utilisés pour le génome viral ?\nPeut-on séquencer un génome viral ?\nQuels symptômes indiquent une infection virale ?\nComment différencier les virus par leur génome ?", "url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Hepatitis+B+virus&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Génome viral", "description": "Quels sont les symptômes d'une infection virale ?\nLes symptômes varient-ils selon le virus ?\nComment les symptômes évoluent-ils ?\nLes symptômes sont-ils toujours présents ?\nQuels symptômes indiquent une complication ?", "url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Hepatitis+B+virus&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Génome viral", "description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures de santé publique aident à prévenir les épidémies ?\nLe port de masque aide-t-il à prévenir les infections ?\nLes voyages augmentent-ils le risque d'infection virale ?", "url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Hepatitis+B+virus&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Génome viral", "description": "Quels traitements existent pour les infections virales ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements varient-ils selon le virus ?\nLes vaccins préviennent-ils toutes les infections virales ?", "url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Hepatitis+B+virus&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Génome viral", "description": "Quelles sont les complications possibles d'une infection virale ?\nComment les complications sont-elles traitées ?\nLes complications sont-elles fréquentes ?\nLes personnes âgées sont-elles plus à risque de complications ?\nComment prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Hepatitis+B+virus&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Génome viral", "description": "Quels sont les facteurs de risque d'infection virale ?\nLe mode de vie influence-t-il le risque d'infection ?\nLes maladies chroniques augmentent-elles le risque ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes contacts fréquents avec des malades augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D016679?mesh_terms=Hepatitis+B+virus&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on un génome viral ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "On utilise des techniques comme la PCR pour identifier le matériel génétique viral." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le génome viral ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques et les tests moléculaires sont couramment utilisés." } }, { "@type": "Question", "name": "Peut-on séquencer un génome viral ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le séquençage permet d'analyser la structure du génome viral." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection virale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue, toux et douleurs musculaires peuvent signaler une infection virale." } }, { "@type": "Question", "name": "Comment différencier les virus par leur génome ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse du type d'acide nucléique (ADN ou ARN) aide à classer les virus." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection virale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fièvre, toux, fatigue, et parfois éruptions cutanées." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le virus ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son type." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours présents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains virus peuvent être asymptomatiques chez certaines personnes." } }, { "@type": "Question", "name": "Quels symptômes indiquent une complication ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des difficultés respiratoires ou des douleurs thoraciques peuvent signaler des complications." } }, { "@type": "Question", "name": "Comment prévenir les infections virales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels." } }, { "@type": "Question", "name": "Les vaccins sont-ils efficaces contre tous les virus ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Non, chaque vaccin cible des virus spécifiques et n'offre pas une protection universelle." } }, { "@type": "Question", "name": "Quelles mesures de santé publique aident à prévenir les épidémies ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance épidémiologique et la vaccination de masse sont cruciales." } }, { "@type": "Question", "name": "Le port de masque aide-t-il à prévenir les infections ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le port de masque réduit la transmission des virus respiratoires." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection virale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages peuvent faciliter la propagation des virus d'une région à une autre." } }, { "@type": "Question", "name": "Quels traitements existent pour les infections virales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antiviraux, les traitements symptomatiques et les vaccins sont utilisés." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre les virus ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales." } }, { "@type": "Question", "name": "Comment les antiviraux agissent-ils ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Ils inhibent la réplication virale ou bloquent l'entrée du virus dans les cellules." } }, { "@type": "Question", "name": "Les traitements varient-ils selon le virus ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virus peut nécessiter un traitement spécifique adapté." } }, { "@type": "Question", "name": "Les vaccins préviennent-ils toutes les infections virales ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Non, les vaccins ne couvrent pas tous les virus, mais protègent contre certains." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une infection virale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure pneumonie, encéphalite ou défaillance organique." } }, { "@type": "Question", "name": "Comment les complications sont-elles traitées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la complication, souvent avec des soins de soutien." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Cela dépend du virus et de l'état de santé de l'individu, certaines infections sont plus risquées." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque de complications ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de complications graves lors d'infections virales." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic précoce et un traitement approprié peuvent réduire le risque de complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque d'infection virale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, l'immunodépression et l'exposition à des personnes infectées." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'infection ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire le risque d'infections virales." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies chroniques peuvent affaiblir le système immunitaire et augmenter le risque." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones à forte incidence de virus peut accroître le risque d'infection." } }, { "@type": "Question", "name": "Les contacts fréquents avec des malades augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, être en contact étroit avec des personnes infectées augmente le risque d'infection." } } ] } ] }

Sources (10000 au total)

Plerixafor and resatorvid inhibit hepatitis B virus

An increase in the demand for a functional cure has accelerated research on new methods of therapy for chronic hepatitis B, which is mainly focused on restoring antiviral immunity for controlling vira... In this study, we generated the Epro-LUC-HepG2 cell model for screening compounds that target EFTUD2. Plerixafor and resatorvid were screened from 261 immunity and inflammation-related compounds due t... The dual-luciferase reporter assays showed that the EFTUD2 promoter hEFTUD2pro-0.5 kb had the strongest activity. In Epro-LUC-HepG2 cells, plerixafor and resatorvid significantly upregulated the activ... We established a convenient model for screening compounds that target EFTUD2 and further identified plerixafor and resatorvid as novel HBV inhibitors...

Hepatitis B virus reactivation in seronegative occult hepatitis B patient receiving ibrutinib therapy.

Ibrutinib is a Bruton's tyrosine kinase (BTK) inhibitor approved for the treatment for several mature B-cell malignancies. Reactivation of hepatitis B virus (HBV) is a well-described complication in p... We report the first case of HBV reactivation during ibrutinib treatment in an asymptomatic 82-year-old woman with seronegative occult hepatitis B patient (i.e., negative for HBsAg, anti-HBc and anti-H... Our case illustrated that in populations with a high incidence of HBV exposure, systematic screening for HBV exposure is essential prior to ibrutinib treatment, followed by serial monitoring of serolo...

The Investigation of Hepatitis B Vaccine Immune Responses in Occult Hepatitis B Virus-Infected Patients.

There is no effective treatment for occult hepatitis B virus infection (OBI) patients, and immunotherapy may be one of the most promising options. We aim to investigate the underlying mechanism and th... Outpatient OBI patients were screened and randomly divided into treatment (Group A) and control (Group B) groups. At weeks 0, 4, and 24, patients in Group A received a subcutaneous/intramuscular injec... Of the 228 OBI patients, 28 were excluded, and 200 were enrolled for observation. In the end, 44 patients were included in Group A and 39 in Group B after excluding lost cases. At week 0 (baseline), s... Anti-HBs in Group A patients were positively correlated with B lymphocytes (r=0.3431, 0.3087, and 0.3041, respectively) and positively correlated with CD8... Virological reactivation is a risk for OBI patients. Serum hepatitis B surface antibodies were significantly increased after hepatitis B vaccine treatment, the same as the numbers of peripheral blood ...

Hepatitis B virus X gene impacts on the innate immunity and immune-tolerant phase in chronic hepatitis B virus infection.

The immunologic features involved in the immune-tolerant phase of chronic hepatitis B (CHB) virus (HBV) infection are unclear. The hepatitis B virus X (HBx) protein disrupts IFN-β induction by downreg... Children with CHB in the immune-tolerant phase were recruited and followed longitudinally. HBx gene sequencing of infecting HBV strains was performed, and the effects of HBx mutations on the immune-to... A total of 173 children (median age, 6.92 years) were recruited. Patients carrying HBx R87G, I127V and R87G + I127V double mutations exhibited higher cumulative incidences of immune-tolerant phase bre... HBx suppresses IFN-β induction. R87G and I127V mutation restored IFN-β production by preventing MAVS degradation, contributing to curtailing the HBV immune-tolerant phase in CHB patients....